StockWatch
·
Pharmaceuticals
Insider Trading28 Sept 2026, 10:37 am

Abbott India: Trading Window Closure for Q2 FY27 Results

AI Summary

Abbott India Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and is in preparation for the declaration of the company's unaudited financial results for the quarter ending September 30, 2026. The trading window will be shut from October 1, 2026, and will reopen 48 hours after the financial results are officially declared. The company secretary, Sangeeta Shetty, has communicated this information.

Key Highlights

  • Trading window closed for designated persons and relatives.
  • Closure is for declaration of Q2 FY27 unaudited financial results.
  • Window opens 48 hours after results are announced.
  • Adheres to SEBI (Prohibition of Insider Trading) Regulations, 2015.